Sumanta Pal, Vice Chair of Academic Affairs at City of Hope, shared a post on X:
“Learned so much from this ESMO25 overview of existing ADCs in bladder cancer by Andrea Necchi in a session hosted by Silke Gillessen and Enrique Grande. The sheer number of trials examining ADCs in bladder cancer is mind-boggling, including multiple phase 3s.”
Follow the latest ESMO 2025 news on OncoDaily.
